News of Note—Indian vaccine controversy, Genocea and more

newspapers
In this week's news of note, Genocea named two new executives. (Pixabay)

Here is some other vaccine news of note for the week:

> Officials in India inadvertently distributed a batch of tainted polio vaccines, but the WHO said the risk of infection for children was "minimal." Reuters article

> Genocea appointed Thomas Davis as its chief medical officer and Derek Meisner as its general counsel. Release

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> OncBioMune kicked off a phase 2 trial of a candidate vaccine to treat prostate cancer. Release

> BlueWIllow Biologics picked up a Small Business Innovation Research grant from the National Institutes of Health to work on a chlamydia vaccine. Release